Let’s Transform Transplant Medicine. Together.
Achieving more through our shared commitment to transplant medicine
See our pipelineLearn more about who we are at Veloxis
Veloxis, an Asahi Kasei company
At Veloxis, our focus is developing new therapies and programs to help transplant healthcare providers and the patients they treat. Now part of a global network, Veloxis is reaching further and growing faster, enabling us to continue being who we are as a company: Agile, Efficient, Responsive. Veloxis is following through on our promise to transform the future of transplant. Let’s transform transplant medicine. Together.
We know what transplant means to patients, and we’re leading innovation to improve their experience
For patients, transplant is a life-changing procedure. But changes come with challenges. At Veloxis, our mission is to see and respond to the challenges along the transplant journey. Our focus is developing new therapies and programs to help transplant healthcare providers and the patients they treat.
As part of a global network, Veloxis is reaching further and growing faster
As an Asahi Kasei company, we are able to expand our presence as a partner in care and innovation in medicine. The support and structured framework we have as part of Asahi Kasei enables us to be who we are as a company: agile, efficient, and responsive.
Meet our leadership
“Veloxis’s Human Resources Department prides itself in providing an exceptional workplace environment for all employees. We strive to maintain a dynamic and innovative workplace that embraces diversity and encourages professional development. Our employees are our top priority!”
Rita Mannella, Executive Director, Human Resources
Keep up with our headlines to see what we’ve been working on
Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia
Veloxis Pharmaceuticals, Inc. (Veloxis), a fully integrated specialty pharmaceutical company, is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).
Veloxis Pharmaceuticals Chief Scientific Officer to Receive National Kidney Foundation’s Market Innovation Award
Ulf Meier-Kriesche, MD, FAST, Chief Scientific Officer of Veloxis Pharmaceuticals, will receive the Market Innovation Award at the National Kidney Foundation’s 1st Annual North Carolina Honors Reception.
Veloxis Pharmaceuticals Partners with Donate Life NC on Gift of Life Gala
Veloxis Pharmaceuticals, a fully integrated specialty pharmaceutical company, is pleased to announce its support of Donate Life North Carolina as the premier sponsor of the 2023 Gift of Life Gala: heART of the Matter on Thursday, April 20th at the Prestonwood Country Club in Cary, N.C.